Last reviewed · How we verify

NCT07143370

Microbial Colonization in Three Dimensional (3D) Printed Orthodontic Clear Aligners

Completed NA Last updated 6 November 2025
What this trial tests

NA trial testing Thermoformed clear aligner in Orthodontic Aligner in 30 participants. Completed in 17 October 2025.

Timeline
2 September 2025
Primary endpoint
17 October 2025
17 October 2025

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment30
Start date2 September 2025
Primary completion17 October 2025
Estimated completion17 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Orthodontic Aligner or Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to compare conventional clear aligners with 3D printed clear aligners to assess if there is any significant difference between the microbial colonization of these appliances. The 3D printed aligner material and conventional aligner materials are being used for investigational purposes and have been approved for their use in fabricating clear aligners for orthodontic tooth movement, but not for the purposes of our study, which is for the fabrication of clear passive aligners to assess microbial colonization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07143370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing